Cargando…

Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers

Detalles Bibliográficos
Autores principales:	Kinsey, Conan G., Camolotto, Soledad A., Boespflug, Amelie M., Gullien, Katrin P., Foth, Mona, Truong, Amanda, Schuman, Sophia S., Shea, Jill E., Seipp, Michael T., Yap, Jeffrey T., Burrell, Lance D., Lum, David H., Whisenant, Jonathan R., Gilcrease, G. Weldon, Cavalieri, Courtney C., Rehbein, Kaitrin M., Cutler, Stephanie L., Affolter, Kajsa E., Welm, Alana L., Welm, Bryan E., Scaife, Courtney L., Snyder, Eric L., McMahon, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452642/ https://www.ncbi.nlm.nih.gov/pubmed/30833748 http://dx.doi.org/10.1038/s41591-019-0367-9

Ejemplares similares

Toward improved models of human cancer
por: Welm, Bryan E., et al.
Publicado: (2021)

AACR Special Conference: Advances in Breast Cancer Research – Genetics, Biology, and Clinical Implications, Huntington Beach, California, USA, 8–12 October 2003
por: Welm, Alana L
Publicado: (2004)

MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition
por: Silvis, Mark R., et al.
Publicado: (2023)

Benefit of adjuvant chemotherapy based on lymph node involvement for oesophageal cancer following trimodality therapy
por: Nevala-Plagemann, Christopher, et al.
Publicado: (2018)

The lingering mysteries of metastatic recurrence in breast cancer
por: Riggio, Alessandra I., et al.
Publicado: (2020)

Immunologically “cold” triple negative breast cancers engraft at a higher rate in patient derived xenografts
por: Petrosyan, Varduhi, et al.
Publicado: (2022)

mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential
por: Faham, Najme, et al.
Publicado: (2018)

Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinoma
por: Affolter, Kajsa E., et al.
Publicado: (2021)

Breast cancer PDxO cultures for drug discovery and functional precision oncology
por: Scherer, Sandra D., et al.
Publicado: (2023)

RON promotes the metastatic spread of breast carcinomas by subverting antitumor immune responses
por: Eyob, Henok, et al.
Publicado: (2013)

Short-form Ron is a novel determinant of ovarian cancer initiation and progression
por: Moxley, Katherine M., et al.
Publicado: (2016)

The small molecule C-6 is selectively cytotoxic against breast cancer cells and its biological action is characterized by mitochondrial defects and endoplasmic reticulum stress
por: Vaden, Rachel M, et al.
Publicado: (2014)

Hemoglobin A1c as a marker to stratify diabetes risk following pancreaticoduodenectomy
por: Bleicher, Josh, et al.
Publicado: (2020)

Targeting the Raf kinases in human cancer: the Raf dimer dilemma
por: Durrant, David E, et al.
Publicado: (2018)

Discrepancies between tumor genomic profiling and germline genetic testing
por: Pauley, K., et al.
Publicado: (2022)

Blocking Short-Form Ron Eliminates Breast Cancer Metastases through Accumulation of Stem-Like CD4(+) T Cells That Subvert Immunosuppression
por: Lai, Shu-Chin Alicia, et al.
Publicado: (2021)

Current management of malignant bowel obstructions: a survey of acute care surgeons and surgical oncologists
por: Bleicher, Josh, et al.
Publicado: (2021)

RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
por: Jin, Ting, et al.
Publicado: (2017)

Protein synthesis inhibitors stimulate MondoA transcriptional activity by driving an accumulation of glucose 6-phosphate
por: Wilde, Blake R., et al.
Publicado: (2020)

Blocking Fibroblast Growth Factor Receptor Signaling Inhibits Tumor Growth, Lymphangiogenesis, and Metastasis
por: Larrieu-Lahargue, Frédéric, et al.
Publicado: (2012)

Inhibition of RON kinase potentiates anti-CTLA-4 immunotherapy to shrink breast tumors and prevent metastatic outgrowth
por: Ekiz, Huseyin Atakan, et al.
Publicado: (2018)

Estrogen receptor alpha mutations regulate gene expression and cell growth in breast cancer through microRNAs
por: Arnesen, Spencer, et al.
Publicado: (2023)

Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland
por: Welm, Bryan E., et al.
Publicado: (2002)

Biomarkers in pancreatic adenocarcinoma: current perspectives
por: Swords, Douglas S, et al.
Publicado: (2016)

Resistance to RAF inhibitors revisited
por: Hartsough, Edward, et al.
Publicado: (2013)

Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential
por: Drobysheva, Daria, et al.
Publicado: (2015)

Fatal Statin-Induced Rhabdomyolysis by Possible Interaction with Palbociclib
por: Nelson, Kellie Lynn, et al.
Publicado: (2017)

Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors
por: Marusiak, Anna A., et al.
Publicado: (2014)

Multianalyte Serum Biomarker Panel for Early Detection of Pancreatic Adenocarcinoma
por: Firpo, Matthew A., et al.
Publicado: (2023)

Survival of patients with metastatic HER2 positive gastro-oesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on front-line chemotherapy plus trastuzumab
por: Nevala-Plagemann, Christopher, et al.
Publicado: (2019)

Patient Perceptions of Decision-making and Quality-of-life Following Surgical Resection of Pancreatic Adenocarcinoma: A Mixed-methods Study
por: Bleicher, Josh, et al.
Publicado: (2022)

Mechanisms of resistance to RAF inhibitors in melanoma
por: Aplin, Andrew E., et al.
Publicado: (2011)

Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion
por: Olson, Michael L., et al.
Publicado: (2022)

“RAF” neighborhood: Protein–protein interaction in the Raf/Mek/Erk pathway
por: Cseh, Botond, et al.
Publicado: (2014)

Development of a screen to identify selective small molecules active against patient-derived metastatic and chemoresistant breast cancer cells
por: Gligorich, Keith M, et al.
Publicado: (2013)

A pharmacogenomic method for individualized prediction of drug sensitivity
por: Cohen, Adam L, et al.
Publicado: (2011)

Raf-mediated cardiac hypertrophy in adult Drosophila
por: Yu, Lin, et al.
Publicado: (2013)

Value of surgical resection and timing of therapy in patients with pancreatic cancer at high risk for positive margins
por: Torgeson, Anna, et al.
Publicado: (2018)

Plasma exosome microRNAs are indicative of breast cancer
por: Hannafon, Bethany N., et al.
Publicado: (2016)

The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming
por: Cunha, Stéphanie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qb0enfkniiedavap03g9n8r3sa